Position in ACAD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,976,162
-$594,965 QoQ
Shares Held
133,700
0.0% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. ACAD ranks #30 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,976,162 | 133,700 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,571,127 | 133,700 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,853,158 | 133,700 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,889,071 | 180,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,024,603 | 242,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,446,205 | 242,300 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,726,574 | 242,300 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,937,375 | 242,300 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $4,480,127 | 242,300 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $4,643,273 | 148,300 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $2,763,384 | 132,600 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $2,169,870 | 90,600 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $1,705,092 | 90,600 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $1,442,352 | 90,600 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $1,482,216 | 90,600 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $1,276,554 | 90,600 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $2,194,332 | 90,600 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $2,369,010 | 101,500 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $1,685,915 | 101,500 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $2,475,585 | 101,500 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $2,618,700 | 101,500 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $5,426,190 | 101,500 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $5,053,125 | 122,500 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $5,040,880 | 104,000 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $4,858,750 | 115,000 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||